产品
编 号：F253750
分子式：C22H22O10
分子量：446.4
分子式：C22H22O10
分子量：446.4
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
792
In-stock
5mg
720
In-stock
10mg
1200
In-stock
50mg
3600
In-stock
结构图
CAS No: 20633-67-4
产品详情
生物活性：
Calycosin-7-O-β-D-glucoside is an isoflavone isolated from Astragali Radix. Calycosin-7-O-β-D-glucoside has variety of biological activities, such as neuroprotective, cardioprotection, anti-inflammation, and antioxidative stress effects.
体内研究：
Calycosin-7-O-β-D-glucoside (intraperitoneal injection; 26.8 mg/kg; 14 days) significantly reduces infarct volume, histological damage and BBB permeability in the in vivo MCAO ischemia-reperfusion rat model.Animal Model:Middle cerebral artery occlusion (MCAO) male adult Sprague-Daweley rats
Dosage:26.8 mg/kg
Administration:Intraperitoneal injection; 26.8 mg/kg; 14 days
Result:Exhibited neuroprotective effects in rats.
体外研究：
Calycosin-7-O-β-D-glucoside (2 μM; 6 hours) remarkably inhibits the expression and activities of MMPs, and secures the expression of cav-1 and tight junction proteins in the microvessels isolated from ischemic rat cortex.
Calycosin-7-O-β-D-glucoside is an isoflavone isolated from Astragali Radix. Calycosin-7-O-β-D-glucoside has variety of biological activities, such as neuroprotective, cardioprotection, anti-inflammation, and antioxidative stress effects.
体内研究：
Calycosin-7-O-β-D-glucoside (intraperitoneal injection; 26.8 mg/kg; 14 days) significantly reduces infarct volume, histological damage and BBB permeability in the in vivo MCAO ischemia-reperfusion rat model.Animal Model:Middle cerebral artery occlusion (MCAO) male adult Sprague-Daweley rats
Dosage:26.8 mg/kg
Administration:Intraperitoneal injection; 26.8 mg/kg; 14 days
Result:Exhibited neuroprotective effects in rats.
体外研究：
Calycosin-7-O-β-D-glucoside (2 μM; 6 hours) remarkably inhibits the expression and activities of MMPs, and secures the expression of cav-1 and tight junction proteins in the microvessels isolated from ischemic rat cortex.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备